With electronic band MGMT’s third disc in the works for months and an expected late 2012 release date already off the table, its label is clearly anxious. So it’s understandable when a Fenway Records ...
Stocktwits on MSN
Disc Medicine stock slides after FDA fast-track approval doubts surface — Wall Street calls it an 'overreaction'
Disc Medicine management said earlier this month that its application seeking approval for Bitopertin has officially been accepted for review on schedule. ・Wall Street analysts dismissed the media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback